Compared side by side

Enclomiphene vs gonadorelin: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

Both aim to raise the body’s own LH and FSH, by different routes: enclomiphene is an oral SERM (not a peptide) that blocks estrogen’s negative feedback at the hypothalamus, while gonadorelin is synthetic GnRH injected 2–3 times a week to stimulate the pituitary directly. Enclomiphene is taken daily as a TRT alternative or after a steroid cycle; gonadorelin is mostly run alongside TRT with the aim of keeping testicular function, a use no published trial has tested. In phase 3 trials enclomiphene raised testosterone while largely keeping sperm production, but it isn’t approved anywhere.

Side by side

ComparedEnclomipheneGonadorelin
CategorySexual healthSexual health
Also known asAndroxal, Trans-clomiphene, Enclomiphene citrateGnRH, Gonadotropin-releasing hormone, Gonadorelin acetate
What it isAn oral medication that blocks estrogen's negative feedback at the hypothalamus, tricking your brain into producing more LH and FSH — which stimulates your body's own testosterone production.A synthetic version of the hormone your hypothalamus uses to signal your pituitary to release LH and FSH — the hormones that drive testosterone production and fertility.
How it worksSelective estrogen receptor modulator (SERM) and the pure trans-isomer of clomiphene. Blocks estrogen negative feedback at the hypothalamus, increasing LH and FSH production which stimulates endogenous testosterone production. Designed to cause fewer estrogenic side effects than clomifene citrate, since it lacks the estrogenic zuclomiphene isomer (no head-to-head trial). SERM, not a peptide — included as it is commonly used in hormonal optimization and TRT-adjacent protocols.Synthetic GnRH (identical to the natural hormone) that stimulates pituitary release of LH and FSH. Used alongside TRT with the aim of maintaining testicular function, testosterone production and fertility; that use hasn't been tested in trials. Continuous exposure (an infusion or long-acting GnRH drugs) shuts the axis down, while intermittent injections of short-lived gonadorelin stimulate it; 2–3x weekly is the common clinic schedule.
Commonly reportedBetter energy and libido over a few weeks as testosterone rises, mood changes such as irritability in some, and occasional visual disturbances that make some people stop. Used as a TRT alternative or in post-cycle therapy (PCT) to restart natural testosterone.Some users on TRT say it helps keep testicular size and fullness compared with TRT alone, and many describe it as weaker than hCG. It's usually injected 2–3 times a week; what shuts the system down is constant exposure (like a drip or long-acting GnRH drugs), not daily use.
Studied rangeResearch range: 12.5–25 mg. Studied in research — not a recommendation.Research range: 100 mcg. Studied in research — not a recommendation.
How oftenDaily2–3x weekly (pulsatile)
Half-life~10 hours~2–10 min
RouteOralSubQ injection
Typical runDaily oral. Used for months in clinical context. Community uses in 3–6 month cycles. Also used as an alternative to TRT (its trials compared it with testosterone gel) and, in the community, after a steroid cycle (PCT).Used continuously alongside TRT with the aim of maintaining testicular function, typically 2–3x/week ongoing.
EvidenceModerate: animal studies + some human dataEstablished: clinical trials or FDA-approved use exists
Common side effectsMood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulatorGenerally well tolerated, injection site reactions, headache

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking enclomiphene or gonadorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

Enclomiphene

  • Day 1–14 LH and FSH climbing, T follows
  • Day 14–84 Steady-state testosterone
  • Day 84–180 Long-term use assessment

Every card for enclomiphene, with its sources

Gonadorelin

  • Day 1–14 Settling into the cadence
  • Day 14–84 Testicular function holding
  • Day 84–365 Long-term maintenance pattern

Every card for gonadorelin, with its sources

Together or one or the other

Enclomiphene and gonadorelin are a common stack: enclomiphene lists gonadorelin among its common stacks.

Questions people ask

How long do enclomiphene and gonadorelin last?

The half-life of enclomiphene is ~10 hours. The half-life of gonadorelin is ~2–10 min.

How often are enclomiphene and gonadorelin taken?

Enclomiphene: daily. Route: Oral. Gonadorelin: 2–3x weekly (pulsatile). Route: SubQ injection.

How are enclomiphene and gonadorelin dosed in research?

The research range for enclomiphene is 12.5–25 mg. The research range for gonadorelin is 100 mcg. Studied in research — not a recommendation.

What are the common side effects of enclomiphene and gonadorelin?

For enclomiphene, the library lists: mood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulator. For gonadorelin: generally well tolerated, injection site reactions, headache.

Are enclomiphene and gonadorelin taken together?

Enclomiphene and gonadorelin are a common stack: enclomiphene lists gonadorelin among its common stacks.

Each one in full

Track it in the app

PepVault for iPhone

Taking enclomiphene or gonadorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo